Skip to main content
Premium Trial:

Request an Annual Quote

Eagle Genomics Selected to Provide Tech Support for Commercial Ensembl Users

Premium

This week, Eagle Genomics said that it will partner with the European Bioinformatics Institute and the Wellcome Trust Sanger Institute to provide technical support for commercial developers and users of the Ensembl platform "who will benefit from an increased range and quality of support options."

The company said that both EBI and the Sanger Institute, who jointly run the database, have agreed to give Eagle access to the "know-how" of Ensembl project members with the goal of providing "commercial-grade support" in areas like user training and the development of plug-ins and modifications.

Paul Flicek, who leads the Ensembl project team at EBI, said the collaboration "extends the reach of Ensembl to those users that require service-level agreements, while benefiting the project through the integration of new features into our open-source platform.”

Under the terms of the agreement, the "collaboration does not provide any privileged access to the content of the Ensembl database … Eagle Genomics retains exactly the same access rights as any other user," the company said.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.